Search Results - "Wang, Cecilia Low"

Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations by Low Wang, Cecilia C, Hess, Connie N, Hiatt, William R, Goldfine, Allison B

“…Cardiovascular disease remains the principal cause of death and disability among patients with diabetes mellitus. Diabetes mellitus exacerbates mechanisms…”
Get full text

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update by Samson, Susan L, Vellanki, Priyathama, Blonde, Lawrence, Christofides, Elena A, Galindo, Rodolfo J, Hirsch, Irl B, Isaacs, Scott D, Izuora, Kenneth E, Low Wang, Cecilia C, Twining, Christine L, Umpierrez, Guillermo E, Valencia, Willy Marcos

“…This consensus statement provides (1) visual guidance in concise graphic algorithms to assist with clinical decision-making of health care professionals in the…”
Get more information

A simple modeling framework for prediction in the human glucose-insulin system by Sirlanci, Melike, Levine, Matthew E, Low Wang, Cecilia C, Albers, David J, Stuart, Andrew M

“…Forecasting blood glucose (BG) levels with routinely collected data is useful for glycemic management. BG dynamics are nonlinear, complex, and nonstationary,…”
Get more information

PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes by Hess, Connie N, Low Wang, Cecilia C, Hiatt, William R

“…Atherosclerotic cardiovascular disease (ASCVD) is associated with significant morbidity and mortality worldwide. Increased serum levels of low-density…”
Get full text

Glucocorticoid-Induced Hyperglycemia Including Dexamethasone-Associated Hyperglycemia in COVID-19 Infection: A Systematic Review by Brooks, Danielle, Schulman-Rosenbaum, Rifka, Griff, Megan, Lester, Janice, Low Wang, Cecilia C

“…Optimal glucocorticoid-induced hyperglycemia (GCIH) management is unclear. The COVID-19 pandemic has made this issue more prominent because dexamethasone…”
Get more information

Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial by Low Wang, Cecilia C, Blomster, Juuso I, Heizer, Gretchen, Berger, Jeffrey S, Baumgartner, Iris, Fowkes, F Gerry R, Held, Peter, Katona, Brian G, Norgren, Lars, Jones, W Schuyler, Lopes, Renato D, Olin, Jeffrey W, Rockhold, Frank W, Mahaffey, Kenneth W, Patel, Manesh R, Hiatt, William R

“…Diabetes confers an increased risk for atherosclerotic cardiovascular disease, but less is known about the independent risk diabetes confers on major…”
Get full text

Macrovascular Complications by McRae, Michael, Low Wang, Cecilia C.

“…Because macrovascular complications of diabetes are the leading cause of mortality and decreased quality of life for individuals with diabetes, prevention and…”
Get full text

Digital Health and Shared Decision-Making in Diabetes Care - A Survey Initiative in Patients and Clinicians by Mubeen, Faiza, Low Wang, Cecilia C, Al Maradni, Ahmad, Shivaswamy, Vijay, Sadhu, Archana R

“…To assess the landscape of digital health resources in the United States, better understand the impact of the digital health on shared decision-making, and…”
Get more information

Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients After Lower Extremity Revascularization by Canonico, Mario Enrico, Low Wang, Cecilia C., Hsia, Judith, Debus, E. Sebastian, Nehler, Mark R., Patel, Manesh R., Anand, Sonia S., Ycas, Joseph, Capell, Warren H., Muehlhofer, Eva, Haskell, Lloyd P., Berkowitz, Scott D., Bauersachs, Rupert, Bonaca, Marc P.

“…Rivaroxaban 2.5 mg plus aspirin reduced limb and cardiovascular events and increased bleeding in patients with symptomatic peripheral artery disease (PAD)…”
Get full text

Cardiovascular Disease in Diabetes: Where Does Glucose Fit In? by Reusch, Jane E. B, Wang, Cecilia C. Low

“…Context: Recent prospective clinical trials have failed to confirm a unique benefit from normalization of glycemia on cardiovascular disease outcomes, despite…”
Get full text

Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology by WANG, Cecilia C, GOALSTONE, Marc L, DRAZNIN, Boris

“…Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology Cecilia C. Low Wang , Marc L. Goalstone and Boris Draznin From the Research…”
Get full text

Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?: Ten Years of FDA Guidance Requirements to Evaluate Cardiovascular Risk by Low Wang, Cecilia C, Everett, Brendan M, Burman, Kenneth D, Wilson, Peter W.F

Get full text

Diabetes and Cardiovascular Disease: Changing the Focus from Glycemic Control to Improving Long-Term Survival by Wang, Cecilia C. Low, MD, Reusch, Jane E.B., MD

“…Diabetes mellitus (DM) is the fifth-leading cause of death worldwide and contributes to leading causes of death, cancer and cardiovascular disease, including…”
Get full text

Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling Pathways by LOW WANG, Cecilia C, GUREVICH, Inga, DRAZNIN, Boris

“…Insulin Affects Vascular Smooth Muscle Cell Phenotype and Migration Via Distinct Signaling Pathways Cecilia C. Low Wang 1 2 , Inga Gurevich 1 and Boris Draznin…”
Get full text

A methodology of phenotyping ICU patients from EHR data: High-fidelity, personalized, and interpretable phenotypes estimation by Wang, Yanran, Stroh, J N, Hripcsak, George, Low Wang, Cecilia C, Bennett, Tellen D, Wrobel, Julia, Der Nigoghossian, Caroline, Mueller, Scott W, Claassen, Jan, Albers, D J

“…Computing phenotypes that provide high-fidelity, time-dependent characterizations and yield personalized interpretations is challenging, especially given the…”
Get full text

Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study by Abushamat, Layla A, Schauer, Irene E, Low Wang, Cecilia C, Mitchell, Stacey, Herlache, Leah, Bridenstine, Mark, Durbin, Roy, Snell-Bergeon, Janet K, Regensteiner, Judith G, Reusch, Jane EB

“…Dysmetabolic states, such as type 2 diabetes (T2D), characterized by insulin resistance (IR), are associated with fatty liver, increased cardiovascular disease…”
Get full text

Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte ® ) to Heal Chronic Diabetic Foot Ulcers by Low Wang, Cecilia C, Chong, Tae, Moore, Garrett, Echalier, Benjamin, Haakonsen, Nicola, Carter, Jr, James E, Mathes, David, Hsia, Judith, Phan, Toan Thang, Lim, Ivor J, Freed, Brian M

“…Mesenchymal stromal/stem cells (MSCs) play a critical role in wound healing. Corlicyte is an MSC product derived from allogeneic umbilical cord tissue donated…”
Get full text

Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution by Rogers, R Kevin, Hiatt, William R, Patel, Manesh R, Shishehbor, Mehdi H, White, Robin, Khan, Naeem D, Bhalla, Narinder P, Jones, W Schuyler, Low Wang, Cecilia C

“…There is limited evidence to guide clinical decision-making for antiplatelet therapy in peripheral artery disease (PAD) in the setting of lower extremity…”
Get full text

USE OF NPH INSULIN FOR GLUCOCORTICOID-INDUCED HYPERGLYCEMIA by Low Wang, Cecilia C, Draznin, Boris

Get more information

Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial by Govsyeyev, Nicholas, Nehler, Mark R., Low Wang, Cecilia C., Kavanagh, Sarah, Hiatt, William R., Long, Chandler, Jones, W. Schuyler, Fowkes, F. Gerry R., Berger, Jeffrey S., Baumgartner, Iris, Patel, Manesh R., Goodney, Philip P., Beckman, Joshua A., Katona, Brian G., Mahaffey, Kenneth W., Blomster, Juuso, Norgren, Lars, Bonaca, Marc P.

“…Amputation remains a frequent and feared outcome in patients with peripheral artery disease (PAD). Although typically characterized as major or minor on the…”
Get full text